Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
Status:
Completed
Trial end date:
2018-10-11
Target enrollment:
Participant gender:
Summary
This was a randomized, double-blind, parallel group, placebo-controlled study, in two
sequential parts that evaluated the renal safety, tolerability and pharmacokinetics of LHW090
in patients with moderately impaired renal function.